Riyadh — Mubasher: Qassim Medical Services Company, a unit of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO), is set to float its shares on the Parallel Market (Nomu). The subsidiary’s general assembly meeting …
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) extended a Sharia-compliant banking facility agreement with Banque Saudi Fransi totaling SAR 104 million. The credit line is specifically designated to fund the …
Riyadh — Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) saw a negotiated (special) deal executed during the 6 September trading session on the Saudi Exchange (Tadawul) at a value of SAR 94.99 million. The …
Riyadh – Mubasher: GIB Capital, acting as the financial advisor and bookrunner, has announced the launch of an accelerated bookbuild offering to sell the entire stake held by the Arab Company for Drug Industries and Medical Appliances (ACDIMA) in …
Riyadh – Mubasher: The Saudi Exchange (Tadawul) has announced the activation of a special session to facilitate an accelerated bookbuild process for the sale of a stake in Saudi Pharmaceutical Industries and Medical Appliances Corporation …
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) renewed its Sharia-compliant banking facility agreement with Alinma Bank on 19 August at a value of SAR 50 million. The credit facility is scheduled for a duration of …
Riyadh – Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) penned a strategic licensing and marketing agreement with China-based Bio-Thera Solutions. Under the terms of the 15-year renewable contract, Avalon Pharma obtained …
Riyadh - Mubasher: The board of Middle East Pharmaceutical Industries Company (Avalon Pharma) approved a cash dividend distribution totaling SAR 28 million for the first half (H1) of 2026. The distribution will target 35 million eligible shares, …
Riyadh - Mubasher: Middle East Pharmaceutical Industries Company (Avalon Pharma) announced a net profit of SAR 55.70 million for the first half (H1) of 2026, marking a 25.99% increase from SAR 44.21 million during the same period in 2025. The …
Riyadh — Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has signed distribution agreements on 29 July 2026 with subsidiaries of Cigalah Medical Company, according to a bourse filing. The contracts appoint …
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed an exclusive agreement with Idorsia Limited for the distribution and commercialization of QUVIVIQ™ (daridorexant) in Saudi Arabia and the Levant region, …
Riyadh – Mubasher: The net profits of Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) surged by 109.82% for the second quarter (Q2) of 2026, reaching SAR 68.40 million. The quarterly results were compared to SAR 32.60 …
Riyadh – Mubasher: The Saudi Exchange (Tadawul) recorded 13 negotiated deals carried out on five listed entities during the 23 July 2026 session. The implemented transactions held a combined value of SAR 166.04 million through a total of 5.67 …
Riyadh – Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) recorded a negotiated transaction valued at SAR 3.52 million during the 23 July 2026 session on the Saudi market. The deal, which was carried out at 12:07, comprised …
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has signed a binding share subscription agreement and a shareholders’ agreement with Lifera, a commercial-scale biopharmaceutical company owned by the Public Investment …
Riyadh - Mubasher: The board of Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) has approved the distribution of SAR 154 million in interim cash dividends to shareholders for the first half (H1) of 2026. The total payout is based on 70 …
Riyadh - Mubasher: Jamjoom Pharmaceuticals Factory Company (Jamjoom Pharma) generated a net profit of SAR 137.63 million for the second quarter (Q2) of 2026, a 4.25% increase from SAR 132.02 million in the prior-year period. The pharmaceutical …
Riyadh – Mubasher: The Saudi Exchange (Tadawul) witnessed the execution of five negotiated deals on Tuesday, 21 July 2026, at a combined value of SAR 340.54 million. The transactions involved a combined volume of 12.46 million shares across four …
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) registered an additional negotiated deal during the 21 July 2026 session on the Saudi market at 15:46. The transaction was valued at SAR 163.17 …
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) saw a negotiated deal amounting to SAR 163.17 million executed during the 21 July 2026 session on the Saudi market at 15:45. The transaction was …
Riyadh – Mubasher: GIB Capital, acting in its capacity as the financial advisor to the Arab Company for Drug Industries and Medical Appliances, commonly known as ACDIMA, has announced the successful completion of a significant share sale in the …
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) recorded a special deal executed on the Saudi Exchange (Tadawul) on 9 July 2026. The transaction was implemented on 3.12 million shares at SAR 27.80 …
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) issued a corrective disclosure regarding its preliminary financial results for the three-month period ended 31 March 2026. The amendment follows an …
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) has entered into a binding agreement to raise its stake in Arabian Medical Products Manufacturing Company (ENAYAH). SPIMACO intends to buy an …
Riyadh – Mubasher: Saudi Pharmaceutical Industries and Medical Appliances Corporation (SPIMACO) penned an agreement to renew and increase Sharia-compliant credit facilities with the Saudi National Bank (SNB) on 11 June 2026. The short-term …
